1. Duburcq A, Charpak Y, Blin P, Madec L. Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex). Rev Epidemiol Sante Publique. 2000;48:363–73.
2. Gatignol C. Opiate replacement therapy in France. Ann Pharm Fr. 2009;67:360–4.
3. Observatoire français des drogues et des toxicomanies: Drogues Chiffres Clés. 4e Ed.
http://www.ofdt.fr/BDD/publications/docs/dcc2012.pdf
. 2012: Accessed October 17, 2014.
4. Costes J-M, Vaissade L, Colasante E, Palle C, Legleye S, Janssen E, et al. Prévalence de l’usage problématique de drogues en France - estimations 2006.
http://www.ofdt.fr/BDD/publications/docs/epfxjcp6.pdf
. 2009: Accessed October 17, 2014.
5. European Monitoring Centre for Drugs and Drug Addiction: 2011 Annual report on the state of the drugs problem in Europe.
http://www.emcdda.europa.eu/publications/annual-report/2011
. 2011: Accessed October 17, 2014.